Safety of pembrolizumab (pem) in patients (pts) who stopped ipilimumab (ipi) due to immune-related adverse events. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract ...

"The overall survival seen in the MAGNITUDE pre-planned multivariate analysis is promising for patients with BRCA -mutated mCRPC, a population more likely to experience poor outcomes," said Kim Chi *, ...

Background: Total hip arthroplasty is a successful surgery, that fails at a rate of approximately 10% at ten years from surgery. Causes for failure are mainly aseptic loosening of one or both ...

To determine the factors that influence component survival we followed a large number of consecutive primary total hip arthroplasties performed in the same Institute. The cohort was large enough to be ...

Immunosuppressive disease is independently associated with significantly shorter survival among patients with CSCC receiving ICI therapy.